Clinical Cancer Research, ISSN 1078-0432, 06/2016, Volume 22, Issue 12, pp. 2929 - 2938
Purpose: Completeness of cytoreductive surgery is a key prognostic factor for survival in patients with ovarian cancer. The ability to differentiate clearly...
MACROMOLECULAR THERAPEUTICS | SURVIVAL | CYTOREDUCTIVE SURGERY | METASTASIS | MECHANISM | ONCOLOGY | RESIDUAL DISEASE | EXPRESSION | EPITHELIAL OVARIAN | CHEMOTHERAPY | FOLATE RECEPTOR-ALPHA | Fluorescent Dyes - pharmacokinetics | Neoplasms, Glandular and Epithelial - diagnostic imaging | Neoplasms, Glandular and Epithelial - pathology | Humans | Middle Aged | Ovarian Neoplasms - pathology | Fluorescent Dyes - adverse effects | Male | Cytoreduction Surgical Procedures - methods | Neoplasms, Glandular and Epithelial - surgery | Ovarian Neoplasms - diagnostic imaging | Young Adult | Folate Receptor 1 - metabolism | Adolescent | Carcinoma, Ovarian Epithelial | Adult | Female | Fluorescent Dyes - pharmacology | Aged | Optical Imaging - methods | Ovarian Neoplasms - surgery
MACROMOLECULAR THERAPEUTICS | SURVIVAL | CYTOREDUCTIVE SURGERY | METASTASIS | MECHANISM | ONCOLOGY | RESIDUAL DISEASE | EXPRESSION | EPITHELIAL OVARIAN | CHEMOTHERAPY | FOLATE RECEPTOR-ALPHA | Fluorescent Dyes - pharmacokinetics | Neoplasms, Glandular and Epithelial - diagnostic imaging | Neoplasms, Glandular and Epithelial - pathology | Humans | Middle Aged | Ovarian Neoplasms - pathology | Fluorescent Dyes - adverse effects | Male | Cytoreduction Surgical Procedures - methods | Neoplasms, Glandular and Epithelial - surgery | Ovarian Neoplasms - diagnostic imaging | Young Adult | Folate Receptor 1 - metabolism | Adolescent | Carcinoma, Ovarian Epithelial | Adult | Female | Fluorescent Dyes - pharmacology | Aged | Optical Imaging - methods | Ovarian Neoplasms - surgery
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2016, Volume 142, Issue 2, pp. 311 - 316
Abstract Objectives To assess the impact of muscle composition and sarcopenia on overall survival in advanced epithelial ovarian cancer (EOC) after primary...
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | Sarcopenia | Skeletal muscle attenuation | Overall survival | Body composition | Ovarian cancer | RENAL-CELL CARCINOMA | COMPUTED-TOMOGRAPHY | OBSTETRICS & GYNECOLOGY | SKELETAL-MUSCLE | PROGNOSTIC-FACTOR | ONCOLOGY | SARCOPENIC OBESITY | ATTENUATION | BODY-MASS INDEX | OUTCOMES | Body Composition | Neoplasms, Glandular and Epithelial - diagnostic imaging | Neoplasms, Glandular and Epithelial - pathology | Humans | Middle Aged | Ovarian Neoplasms - pathology | Sarcopenia - diagnostic imaging | Ovarian Neoplasms - complications | Neoplasms, Glandular and Epithelial - surgery | Neoplasms, Glandular and Epithelial - complications | Ovarian Neoplasms - diagnostic imaging | Sarcopenia - etiology | Muscle, Skeletal - diagnostic imaging | Carcinoma, Ovarian Epithelial | Female | Aged | Muscle, Skeletal - pathology | Neoplasm Staging | Cohort Studies | Ovarian Neoplasms - surgery | CT imaging | Patient outcomes | Medical research | Analysis | Muscles | Medicine, Experimental | Risk factors
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | Sarcopenia | Skeletal muscle attenuation | Overall survival | Body composition | Ovarian cancer | RENAL-CELL CARCINOMA | COMPUTED-TOMOGRAPHY | OBSTETRICS & GYNECOLOGY | SKELETAL-MUSCLE | PROGNOSTIC-FACTOR | ONCOLOGY | SARCOPENIC OBESITY | ATTENUATION | BODY-MASS INDEX | OUTCOMES | Body Composition | Neoplasms, Glandular and Epithelial - diagnostic imaging | Neoplasms, Glandular and Epithelial - pathology | Humans | Middle Aged | Ovarian Neoplasms - pathology | Sarcopenia - diagnostic imaging | Ovarian Neoplasms - complications | Neoplasms, Glandular and Epithelial - surgery | Neoplasms, Glandular and Epithelial - complications | Ovarian Neoplasms - diagnostic imaging | Sarcopenia - etiology | Muscle, Skeletal - diagnostic imaging | Carcinoma, Ovarian Epithelial | Female | Aged | Muscle, Skeletal - pathology | Neoplasm Staging | Cohort Studies | Ovarian Neoplasms - surgery | CT imaging | Patient outcomes | Medical research | Analysis | Muscles | Medicine, Experimental | Risk factors
Journal Article
Radiographics, ISSN 0271-5333, 2017, Volume 37, Issue 3, pp. 758 - 776
Thymic epithelial neoplasms are rare malignancies that arise from the thymus and include thymoma, thymic carcinoma, and thymic neuroendocrine tumors. At least...
Diagnostic Imaging | Neoplasms, Glandular and Epithelial - diagnostic imaging | Neoplasms, Glandular and Epithelial - pathology | Thymus Neoplasms - diagnostic imaging | Lymph Nodes - pathology | Lymphatic Metastasis - diagnostic imaging | Humans | Lymphatic Metastasis - pathology | Thymus Neoplasms - pathology | Neoplasm Staging | Lymph Nodes - diagnostic imaging
Diagnostic Imaging | Neoplasms, Glandular and Epithelial - diagnostic imaging | Neoplasms, Glandular and Epithelial - pathology | Thymus Neoplasms - diagnostic imaging | Lymph Nodes - pathology | Lymphatic Metastasis - diagnostic imaging | Humans | Lymphatic Metastasis - pathology | Thymus Neoplasms - pathology | Neoplasm Staging | Lymph Nodes - diagnostic imaging
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 13, pp. 1411 - 1420
Purpose To establish the performance of screening with serum cancer antigen 125 (CA-125), interpreted using the risk of ovarian cancer algorithm (ROCA), and...
MORTALITY | SURVIVAL | POPULATION | ONCOLOGY | MUTATION CARRIERS | HIGH-RISK | REDUCING SALPINGO-OOPHORECTOMY | RANDOMIZED CONTROLLED-TRIAL | BRCA1/2 MUTATIONS | BREAST | COLLABORATIVE TRIAL | Prospective Studies | Early Detection of Cancer - methods | Humans | Middle Aged | Ovarian Neoplasms - pathology | Ovarian Neoplasms - diagnostic imaging | Fallopian Tube Neoplasms - blood | Neoplasms, Glandular and Epithelial - blood | Aged, 80 and over | Adult | Female | Membrane Proteins - blood | Ultrasonography - methods | Neoplasms, Glandular and Epithelial - diagnostic imaging | Neoplasms, Glandular and Epithelial - pathology | Fallopian Tube Neoplasms - diagnostic imaging | CA-125 Antigen - blood | Ovarian Neoplasms - blood | Fallopian Tube Neoplasms - pathology | United Kingdom | Algorithms | Carcinoma, Ovarian Epithelial | Aged | Neoplasm Staging | Cohort Studies | ORIGINAL REPORTS
MORTALITY | SURVIVAL | POPULATION | ONCOLOGY | MUTATION CARRIERS | HIGH-RISK | REDUCING SALPINGO-OOPHORECTOMY | RANDOMIZED CONTROLLED-TRIAL | BRCA1/2 MUTATIONS | BREAST | COLLABORATIVE TRIAL | Prospective Studies | Early Detection of Cancer - methods | Humans | Middle Aged | Ovarian Neoplasms - pathology | Ovarian Neoplasms - diagnostic imaging | Fallopian Tube Neoplasms - blood | Neoplasms, Glandular and Epithelial - blood | Aged, 80 and over | Adult | Female | Membrane Proteins - blood | Ultrasonography - methods | Neoplasms, Glandular and Epithelial - diagnostic imaging | Neoplasms, Glandular and Epithelial - pathology | Fallopian Tube Neoplasms - diagnostic imaging | CA-125 Antigen - blood | Ovarian Neoplasms - blood | Fallopian Tube Neoplasms - pathology | United Kingdom | Algorithms | Carcinoma, Ovarian Epithelial | Aged | Neoplasm Staging | Cohort Studies | ORIGINAL REPORTS
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2013, Volume 131, Issue 2, pp. 389 - 394
Abstract Objective The use of tumor debulking surgery in the management of epithelial ovarian cancer (EOC), which is often disseminated in the peritoneal...
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | Operability | Preoperative imaging | Staging | PET/CT | Ovarian cancer | SURGERY | SURVIVAL | F-18-FDG PET/CT | PERITONEAL CARCINOMATOSIS | COMPUTED-TOMOGRAPHY | DIAGNOSTIC-ACCURACY | OBSTETRICS & GYNECOLOGY | LYMPH-NODE METASTASIS | NEOADJUVANT CHEMOTHERAPY | ONCOLOGY | SUBOPTIMAL PRIMARY CYTOREDUCTION | LAPAROSCOPY | Neoplasms, Glandular and Epithelial - diagnostic imaging | Neoplasms, Glandular and Epithelial - pathology | Prospective Studies | Ovarian Neoplasms - diagnosis | Humans | Middle Aged | Ovarian Neoplasms - pathology | Tomography, X-Ray Computed - methods | Positron-Emission Tomography - methods | Neoplasm Staging - methods | Ovarian Neoplasms - diagnostic imaging | Multimodal Imaging - methods | Carcinoma, Ovarian Epithelial | Female | Fluorodeoxyglucose F18 | Aged | Neoplasms, Glandular and Epithelial - diagnosis | Radiopharmaceuticals | Comparative analysis | CT imaging
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | Operability | Preoperative imaging | Staging | PET/CT | Ovarian cancer | SURGERY | SURVIVAL | F-18-FDG PET/CT | PERITONEAL CARCINOMATOSIS | COMPUTED-TOMOGRAPHY | DIAGNOSTIC-ACCURACY | OBSTETRICS & GYNECOLOGY | LYMPH-NODE METASTASIS | NEOADJUVANT CHEMOTHERAPY | ONCOLOGY | SUBOPTIMAL PRIMARY CYTOREDUCTION | LAPAROSCOPY | Neoplasms, Glandular and Epithelial - diagnostic imaging | Neoplasms, Glandular and Epithelial - pathology | Prospective Studies | Ovarian Neoplasms - diagnosis | Humans | Middle Aged | Ovarian Neoplasms - pathology | Tomography, X-Ray Computed - methods | Positron-Emission Tomography - methods | Neoplasm Staging - methods | Ovarian Neoplasms - diagnostic imaging | Multimodal Imaging - methods | Carcinoma, Ovarian Epithelial | Female | Fluorodeoxyglucose F18 | Aged | Neoplasms, Glandular and Epithelial - diagnosis | Radiopharmaceuticals | Comparative analysis | CT imaging
Journal Article
Journal of Magnetic Resonance Imaging, ISSN 1053-1807, 11/2017, Volume 46, Issue 5, pp. 1499 - 1506
Purpose To investigate the use of diffusion kurtosis imaging (DKI) in differentiating borderline from malignant epithelial ovarian tumors (MEOTs) and to...
borderline | diffusion kurtosis imaging | magnetic resonance imaging | ovarian tumors | WEIGHTED MRI | BONE-MARROW | IN-VIVO | METASTASES | INTRAVOXEL INCOHERENT MOTION | CERVICAL-CANCER | PERFUSION | RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | CHEMOTHERAPY | RADIATION-THERAPY | Immunohistochemistry | Neoplasms, Glandular and Epithelial - diagnostic imaging | Reproducibility of Results | Humans | Middle Aged | Neoplasms, Glandular and Epithelial - metabolism | Ki-67 Antigen - metabolism | Diffusion Tensor Imaging | Ovarian Neoplasms - diagnostic imaging | Young Adult | Image Processing, Computer-Assisted | Sensitivity and Specificity | Diffusion Magnetic Resonance Imaging | Carcinoma, Ovarian Epithelial | Adult | Female | Aged | Ovarian Neoplasms - metabolism | Observer Variation | Diagnostic imaging | Ovarian cancer | Nuclear magnetic resonance--NMR | Magnetic resonance imaging | Correlation analysis | Kurtosis | Diagnostic systems | Added value | Diffusion coefficient | Tumors
borderline | diffusion kurtosis imaging | magnetic resonance imaging | ovarian tumors | WEIGHTED MRI | BONE-MARROW | IN-VIVO | METASTASES | INTRAVOXEL INCOHERENT MOTION | CERVICAL-CANCER | PERFUSION | RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | CHEMOTHERAPY | RADIATION-THERAPY | Immunohistochemistry | Neoplasms, Glandular and Epithelial - diagnostic imaging | Reproducibility of Results | Humans | Middle Aged | Neoplasms, Glandular and Epithelial - metabolism | Ki-67 Antigen - metabolism | Diffusion Tensor Imaging | Ovarian Neoplasms - diagnostic imaging | Young Adult | Image Processing, Computer-Assisted | Sensitivity and Specificity | Diffusion Magnetic Resonance Imaging | Carcinoma, Ovarian Epithelial | Adult | Female | Aged | Ovarian Neoplasms - metabolism | Observer Variation | Diagnostic imaging | Ovarian cancer | Nuclear magnetic resonance--NMR | Magnetic resonance imaging | Correlation analysis | Kurtosis | Diagnostic systems | Added value | Diffusion coefficient | Tumors
Journal Article
Cancer Research, ISSN 0008-5472, 06/2017, Volume 77, Issue 11, pp. 2903 - 2913
Ovarian high-grade serous carcinoma (HGSC) results in the highest mortality among gynecological cancers, developing rapidly and aggressively. Dissimilarly,...
BREAST-CANCER | PATHOGENESIS | BIOMARKERS | DIAGNOSIS | HUMAN BRAIN-TUMORS | ONCOLOGY | LIPIDOMIC ANALYSIS | TISSUE | GRADE | CARCINOMA | FEATURES | Ovarian Neoplasms - diagnostic imaging | Neoplasms, Glandular and Epithelial - diagnostic imaging | Neoplasms, Glandular and Epithelial - pathology | Spectrometry, Mass, Electrospray Ionization - methods | Humans | Ovarian Neoplasms - pathology | Biomarkers, Tumor - metabolism | Carcinoma, Ovarian Epithelial | Female | Cystadenocarcinoma, Serous - pathology | Cystadenocarcinoma, Serous - diagnostic imaging | Carcinoma | Ovarian carcinoma | Spatial discrimination | Lipids | Statistical methods | Tissues | Ovarian cancer | Metabolites | Quality | Classification | Mathematical models | Diagnosis | Lipid metabolism | Signatures | Evaluation | Spectroscopy | Statistical analysis | Aggressive behavior | Markers | Stroma | Ions | Mass spectroscopy | Metabolism | Fatty acids | Disease control | Complex lipids | Ionization | Predictions | Scientific imaging | Diagnostic systems | Mass spectrometry | Tumors | Cancer
BREAST-CANCER | PATHOGENESIS | BIOMARKERS | DIAGNOSIS | HUMAN BRAIN-TUMORS | ONCOLOGY | LIPIDOMIC ANALYSIS | TISSUE | GRADE | CARCINOMA | FEATURES | Ovarian Neoplasms - diagnostic imaging | Neoplasms, Glandular and Epithelial - diagnostic imaging | Neoplasms, Glandular and Epithelial - pathology | Spectrometry, Mass, Electrospray Ionization - methods | Humans | Ovarian Neoplasms - pathology | Biomarkers, Tumor - metabolism | Carcinoma, Ovarian Epithelial | Female | Cystadenocarcinoma, Serous - pathology | Cystadenocarcinoma, Serous - diagnostic imaging | Carcinoma | Ovarian carcinoma | Spatial discrimination | Lipids | Statistical methods | Tissues | Ovarian cancer | Metabolites | Quality | Classification | Mathematical models | Diagnosis | Lipid metabolism | Signatures | Evaluation | Spectroscopy | Statistical analysis | Aggressive behavior | Markers | Stroma | Ions | Mass spectroscopy | Metabolism | Fatty acids | Disease control | Complex lipids | Ionization | Predictions | Scientific imaging | Diagnostic systems | Mass spectrometry | Tumors | Cancer
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2015, Volume 10, Issue 10, p. e0140403
Objective Tumor cachexia is an important prognostic parameter in epithelial ovarian cancer (EOC). Tumor cachexia is characterized by metabolic and inflammatory...
PATHOGENESIS | CYTOKINES | PLASMA | PROTEIN | SERUM-ALBUMIN | INFLAMMATION | MULTIDISCIPLINARY SCIENCES | CLINICAL-IMPLICATIONS | SARCOPENIA | INTERLEUKIN-10 | PATHOPHYSIOLOGY | Body Composition | Neoplasms, Glandular and Epithelial - diagnostic imaging | Prognosis | Humans | Middle Aged | Ovarian Neoplasms - blood | Ovarian Neoplasms - complications | Cachexia - blood | Biomarkers, Tumor - blood | Neoplasms, Glandular and Epithelial - complications | Ovarian Neoplasms - diagnostic imaging | Radiography | Neoplasms, Glandular and Epithelial - blood | Muscle, Skeletal - diagnostic imaging | Cachexia - etiology | Cachexia - diagnostic imaging | Carcinoma, Ovarian Epithelial | Female | Aged | Cytokines - blood | Tumor markers | Cytokines | Analysis | Physiological aspects | Cachexia | Research | Ovarian cancer | Multiplexing | Ovarian carcinoma | Laboratories | Life assessment | Oncology | Multivariate analysis | Body composition | Eotaxin | Proteins | Computed tomography | Body composition (biology) | Surgery | Tumor necrosis factor-TNF | Medical research | Medical imaging | Parameters | Gynecology | Markers | Muscles | Inflammation | Regression analysis | Metabolism | Patients | Survival | Skeletal muscle | Musculoskeletal system | Medical prognosis | Interleukin 10 | Cancer | Tumors
PATHOGENESIS | CYTOKINES | PLASMA | PROTEIN | SERUM-ALBUMIN | INFLAMMATION | MULTIDISCIPLINARY SCIENCES | CLINICAL-IMPLICATIONS | SARCOPENIA | INTERLEUKIN-10 | PATHOPHYSIOLOGY | Body Composition | Neoplasms, Glandular and Epithelial - diagnostic imaging | Prognosis | Humans | Middle Aged | Ovarian Neoplasms - blood | Ovarian Neoplasms - complications | Cachexia - blood | Biomarkers, Tumor - blood | Neoplasms, Glandular and Epithelial - complications | Ovarian Neoplasms - diagnostic imaging | Radiography | Neoplasms, Glandular and Epithelial - blood | Muscle, Skeletal - diagnostic imaging | Cachexia - etiology | Cachexia - diagnostic imaging | Carcinoma, Ovarian Epithelial | Female | Aged | Cytokines - blood | Tumor markers | Cytokines | Analysis | Physiological aspects | Cachexia | Research | Ovarian cancer | Multiplexing | Ovarian carcinoma | Laboratories | Life assessment | Oncology | Multivariate analysis | Body composition | Eotaxin | Proteins | Computed tomography | Body composition (biology) | Surgery | Tumor necrosis factor-TNF | Medical research | Medical imaging | Parameters | Gynecology | Markers | Muscles | Inflammation | Regression analysis | Metabolism | Patients | Survival | Skeletal muscle | Musculoskeletal system | Medical prognosis | Interleukin 10 | Cancer | Tumors
Journal Article
Obstetrics & Gynecology, ISSN 0029-7844, 12/2011, Volume 118, Issue 6, pp. 1212 - 1221
OBJECTIVE:To estimate the effect of ultrasonographic screening on stage at detection and long-term disease-specific survival of women with epithelial ovarian...
TRANSVAGINAL SONOGRAPHY | MORTALITY | PROSTATE | DIAGNOSIS | LUNG | RANDOMIZED-TRIAL | TUMORS | AGE | OBSTETRICS & GYNECOLOGY | Neoplasms, Glandular and Epithelial - diagnostic imaging | Neoplasms, Glandular and Epithelial - pathology | Ovary - pathology | Humans | Middle Aged | Ovarian Neoplasms - pathology | Survival Rate | Ovarian Neoplasms - mortality | Ovarian Neoplasms - diagnostic imaging | Mass Screening | Neoplasms, Glandular and Epithelial - mortality | Kentucky - epidemiology | Ultrasonography | Aged, 80 and over | Adult | Female | Aged | Neoplasm Staging
TRANSVAGINAL SONOGRAPHY | MORTALITY | PROSTATE | DIAGNOSIS | LUNG | RANDOMIZED-TRIAL | TUMORS | AGE | OBSTETRICS & GYNECOLOGY | Neoplasms, Glandular and Epithelial - diagnostic imaging | Neoplasms, Glandular and Epithelial - pathology | Ovary - pathology | Humans | Middle Aged | Ovarian Neoplasms - pathology | Survival Rate | Ovarian Neoplasms - mortality | Ovarian Neoplasms - diagnostic imaging | Mass Screening | Neoplasms, Glandular and Epithelial - mortality | Kentucky - epidemiology | Ultrasonography | Aged, 80 and over | Adult | Female | Aged | Neoplasm Staging
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 01/2016, Volume 140, Issue 1, pp. 29 - 35
The aim of this study was to examine the relationship between the reduction of maximum standardized uptake values (SUVmax) in F-FDG-PET/CT to histopathological...
Neoadjuvant chemotherapy | Histopathological response | Treatment response evaluation | Epithelial ovarian cancer | 18F-FDGPET/CT | F-FDGPET/CT | Fluorodeoxyglucose F18 - analysis | Humans | Ovarian Neoplasms - pathology | Tomography, X-Ray Computed - methods | Radiopharmaceuticals - analysis | Ovarian Neoplasms - diagnostic imaging | Organoplatinum Compounds - administration & dosage | Multimodal Imaging - methods | Female | Neoadjuvant Therapy | Retrospective Studies | Chemotherapy, Adjuvant | Ovarian Neoplasms - drug therapy | Neoplasms, Glandular and Epithelial - diagnostic imaging | Neoplasms, Glandular and Epithelial - pathology | Reproducibility of Results | Models, Statistical | Positron-Emission Tomography - methods | Neoplasms, Glandular and Epithelial - surgery | Regression Analysis | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasms, Glandular and Epithelial - drug therapy | Carcinoma, Ovarian Epithelial | Aged | Ovarian Neoplasms - surgery
Neoadjuvant chemotherapy | Histopathological response | Treatment response evaluation | Epithelial ovarian cancer | 18F-FDGPET/CT | F-FDGPET/CT | Fluorodeoxyglucose F18 - analysis | Humans | Ovarian Neoplasms - pathology | Tomography, X-Ray Computed - methods | Radiopharmaceuticals - analysis | Ovarian Neoplasms - diagnostic imaging | Organoplatinum Compounds - administration & dosage | Multimodal Imaging - methods | Female | Neoadjuvant Therapy | Retrospective Studies | Chemotherapy, Adjuvant | Ovarian Neoplasms - drug therapy | Neoplasms, Glandular and Epithelial - diagnostic imaging | Neoplasms, Glandular and Epithelial - pathology | Reproducibility of Results | Models, Statistical | Positron-Emission Tomography - methods | Neoplasms, Glandular and Epithelial - surgery | Regression Analysis | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasms, Glandular and Epithelial - drug therapy | Carcinoma, Ovarian Epithelial | Aged | Ovarian Neoplasms - surgery
Journal Article
11.
Full Text
Surgical management of cardiophrenic lymph nodes in patients with advanced ovarian cancer
Gynecologic Oncology, ISSN 0090-8258, 2016, Volume 141, Issue 2, pp. 271 - 275
Abstract Objective Debulking surgery for advanced ovarian cancer does not routinely include opening of the thorax. Even systematic lymphadenectomy does not...
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | Lymphadenectomy | Cardiophrenic lymph nodes | Advanced ovarian cancer | Primary debulking surgery | DIAGNOSIS | METASTASIS | COMPUTED-TOMOGRAPHY SCAN | ENLARGEMENT | CYTOREDUCTION | OBSTETRICS & GYNECOLOGY | ONCOLOGY | PROGNOSTIC-SIGNIFICANCE | ASSISTED THORACIC-SURGERY | Neoplasms, Glandular and Epithelial - diagnostic imaging | Neoplasms, Glandular and Epithelial - pathology | Diaphragm - pathology | Lymph Nodes - pathology | Lymph Nodes - surgery | Humans | Middle Aged | Ovarian Neoplasms - pathology | Diaphragm - diagnostic imaging | Neoplasms, Glandular and Epithelial - surgery | Ovarian Neoplasms - diagnostic imaging | Pericardium - pathology | Carcinoma, Ovarian Epithelial | Adult | Female | Pericardium - diagnostic imaging | Aged | Diaphragm - surgery | Pericardium - surgery | Lymph Node Excision - methods | Lymph Nodes - diagnostic imaging | Ovarian Neoplasms - surgery | Care and treatment | Cancer patients | Ovarian cancer | Complications and side effects
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | Lymphadenectomy | Cardiophrenic lymph nodes | Advanced ovarian cancer | Primary debulking surgery | DIAGNOSIS | METASTASIS | COMPUTED-TOMOGRAPHY SCAN | ENLARGEMENT | CYTOREDUCTION | OBSTETRICS & GYNECOLOGY | ONCOLOGY | PROGNOSTIC-SIGNIFICANCE | ASSISTED THORACIC-SURGERY | Neoplasms, Glandular and Epithelial - diagnostic imaging | Neoplasms, Glandular and Epithelial - pathology | Diaphragm - pathology | Lymph Nodes - pathology | Lymph Nodes - surgery | Humans | Middle Aged | Ovarian Neoplasms - pathology | Diaphragm - diagnostic imaging | Neoplasms, Glandular and Epithelial - surgery | Ovarian Neoplasms - diagnostic imaging | Pericardium - pathology | Carcinoma, Ovarian Epithelial | Adult | Female | Pericardium - diagnostic imaging | Aged | Diaphragm - surgery | Pericardium - surgery | Lymph Node Excision - methods | Lymph Nodes - diagnostic imaging | Ovarian Neoplasms - surgery | Care and treatment | Cancer patients | Ovarian cancer | Complications and side effects
Journal Article
British Journal of Cancer, ISSN 0007-0920, 06/2013, Volume 108, Issue 12, pp. 2448 - 2454
Background: Correct characterisation of ovarian tumours is critical to optimise patient care. The purpose of this study is to evaluate the diagnostic...
SURGERY | DIAGNOSIS | ovarian cancer | ultrasonography | ovarian neoplasm | OVARIAN-CANCER | LOGISTIC-REGRESSION MODEL | TUMOR-ANALYSIS IOTA | MALIGNANCY | decision support techniques | ULTRASOUND | ONCOLOGY | BENIGN | Biomarkers | ADNEXAL MASSES | CARCINOMA | CA125 antigen | Models, Theoretical | Clinical Competence | Neoplasms, Glandular and Epithelial - diagnostic imaging | Prevalence | Prognosis | Cross-Sectional Studies | Risk Assessment | Health Status Indicators | Ovarian Neoplasms - diagnosis | Humans | Middle Aged | Neoplasms, Glandular and Epithelial - epidemiology | Ovarian Neoplasms - epidemiology | Ovarian Neoplasms - diagnostic imaging | Internationality | Education, Medical | Ultrasonography | Carcinoma, Ovarian Epithelial | Adult | Female | Neoplasms, Glandular and Epithelial - diagnosis | Ovarian Neoplasms - etiology | Neoplasms, Glandular and Epithelial - etiology | Observer Variation | Clinical Study
SURGERY | DIAGNOSIS | ovarian cancer | ultrasonography | ovarian neoplasm | OVARIAN-CANCER | LOGISTIC-REGRESSION MODEL | TUMOR-ANALYSIS IOTA | MALIGNANCY | decision support techniques | ULTRASOUND | ONCOLOGY | BENIGN | Biomarkers | ADNEXAL MASSES | CARCINOMA | CA125 antigen | Models, Theoretical | Clinical Competence | Neoplasms, Glandular and Epithelial - diagnostic imaging | Prevalence | Prognosis | Cross-Sectional Studies | Risk Assessment | Health Status Indicators | Ovarian Neoplasms - diagnosis | Humans | Middle Aged | Neoplasms, Glandular and Epithelial - epidemiology | Ovarian Neoplasms - epidemiology | Ovarian Neoplasms - diagnostic imaging | Internationality | Education, Medical | Ultrasonography | Carcinoma, Ovarian Epithelial | Adult | Female | Neoplasms, Glandular and Epithelial - diagnosis | Ovarian Neoplasms - etiology | Neoplasms, Glandular and Epithelial - etiology | Observer Variation | Clinical Study
Journal Article
Journal of Magnetic Resonance Imaging, ISSN 1053-1807, 12/2017, Volume 46, Issue 6, pp. 1797 - 1809
Purpose To evaluate the utility of histogram analysis of monoexponential, biexponential, and stretchedāexponential models to a dualistic model of epithelial...
histogram | magnetic resonance imaging | ovarian cancer | intravoxel incoherent motion | quantitative study | WEIGHTED MRI | CERVICAL-CANCER | DUALISTIC MODEL | INTRAVOXEL-INCOHERENT-MOTION | FEATURES | NASOPHARYNGEAL CARCINOMA | HISTOLOGIC GRADE | COEFFICIENT | PERFUSION FRACTION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | ENDOTHELIAL GROWTH-FACTOR | Neoplasms, Glandular and Epithelial - diagnostic imaging | Diagnosis, Differential | Reproducibility of Results | Humans | Image Interpretation, Computer-Assisted - methods | Middle Aged | Image Processing, Computer-Assisted - methods | Ovarian Neoplasms - diagnostic imaging | Sensitivity and Specificity | Ovary - diagnostic imaging | Carcinoma, Ovarian Epithelial | Adult | Female | Aged | Diffusion Magnetic Resonance Imaging - methods | Ovarian cancer | Nuclear magnetic resonance--NMR | Ovarian carcinoma | Histograms | Magnetic resonance imaging | Perfusion | Quality | Morphology | Implants | Models | Diffusion coefficient | Diffusion | Peritoneum | Cancer
histogram | magnetic resonance imaging | ovarian cancer | intravoxel incoherent motion | quantitative study | WEIGHTED MRI | CERVICAL-CANCER | DUALISTIC MODEL | INTRAVOXEL-INCOHERENT-MOTION | FEATURES | NASOPHARYNGEAL CARCINOMA | HISTOLOGIC GRADE | COEFFICIENT | PERFUSION FRACTION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | ENDOTHELIAL GROWTH-FACTOR | Neoplasms, Glandular and Epithelial - diagnostic imaging | Diagnosis, Differential | Reproducibility of Results | Humans | Image Interpretation, Computer-Assisted - methods | Middle Aged | Image Processing, Computer-Assisted - methods | Ovarian Neoplasms - diagnostic imaging | Sensitivity and Specificity | Ovary - diagnostic imaging | Carcinoma, Ovarian Epithelial | Adult | Female | Aged | Diffusion Magnetic Resonance Imaging - methods | Ovarian cancer | Nuclear magnetic resonance--NMR | Ovarian carcinoma | Histograms | Magnetic resonance imaging | Perfusion | Quality | Morphology | Implants | Models | Diffusion coefficient | Diffusion | Peritoneum | Cancer
Journal Article
International Journal of Cancer, ISSN 0020-7136, 06/2018, Volume 142, Issue 11, pp. 2375 - 2382
Thymic epithelial tumors are rare malignancies, and no optimal therapeutic regimen has been defined for patients with advanced disease. Patients with advanced...
thymic carcinoma | thymoma | WT1 | WT1 peptide vaccine | CELLS | GLIOBLASTOMA-MULTIFORME | VACCINATION | ACUTE MYELOID-LEUKEMIA | INDUCTION | TUMOR GENE WT1 | CYTOTOXIC T-LYMPHOCYTES | OVEREXPRESSION | ONCOLOGY | HELPER PEPTIDE | Immunohistochemistry | WT1 Proteins - metabolism | Humans | Middle Aged | Male | Tomography, X-Ray Computed | Neoplasms, Glandular and Epithelial - immunology | Cancer Vaccines - therapeutic use | Thymus Neoplasms - immunology | WT1 Proteins - chemistry | Immunotherapy | Thymus Neoplasms - pathology | WT1 Proteins - immunology | Adult | Female | Neoplasms, Glandular and Epithelial - diagnostic imaging | Neoplasms, Glandular and Epithelial - pathology | Gene Expression | Thymus Neoplasms - diagnostic imaging | Peptides - immunology | Treatment Outcome | Combined Modality Therapy | Thymus Neoplasms - drug therapy | Cancer Vaccines - immunology | Neoplasms, Glandular and Epithelial - drug therapy | Aged | Neoplasm Staging | Medical research | Myasthenia gravis | Peptides | Medicine, Experimental | Development and progression | Cancer | Cerebellum | Immune response | Thymoma | Complications | Invasiveness | Hemorrhage | Patients | Thymus | Aplasia | Neuromuscular junctions | Myasthenia | Tumors
thymic carcinoma | thymoma | WT1 | WT1 peptide vaccine | CELLS | GLIOBLASTOMA-MULTIFORME | VACCINATION | ACUTE MYELOID-LEUKEMIA | INDUCTION | TUMOR GENE WT1 | CYTOTOXIC T-LYMPHOCYTES | OVEREXPRESSION | ONCOLOGY | HELPER PEPTIDE | Immunohistochemistry | WT1 Proteins - metabolism | Humans | Middle Aged | Male | Tomography, X-Ray Computed | Neoplasms, Glandular and Epithelial - immunology | Cancer Vaccines - therapeutic use | Thymus Neoplasms - immunology | WT1 Proteins - chemistry | Immunotherapy | Thymus Neoplasms - pathology | WT1 Proteins - immunology | Adult | Female | Neoplasms, Glandular and Epithelial - diagnostic imaging | Neoplasms, Glandular and Epithelial - pathology | Gene Expression | Thymus Neoplasms - diagnostic imaging | Peptides - immunology | Treatment Outcome | Combined Modality Therapy | Thymus Neoplasms - drug therapy | Cancer Vaccines - immunology | Neoplasms, Glandular and Epithelial - drug therapy | Aged | Neoplasm Staging | Medical research | Myasthenia gravis | Peptides | Medicine, Experimental | Development and progression | Cancer | Cerebellum | Immune response | Thymoma | Complications | Invasiveness | Hemorrhage | Patients | Thymus | Aplasia | Neuromuscular junctions | Myasthenia | Tumors
Journal Article